Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 3Gynecologic 2Breast 2Head & Neck 1

Conditions

Rectal Neoplasms 1Pathologic Processes 1Pancreatic Neoplasms 1Neoplastic Processes 1Neoplasms 1Liver Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Electrochemotherapy × Gastrointestinal × Clear all
NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed
25 enrolled 6 charts
Gastrointestinal

Liver Neoplasms

NCT03040180 2019-01-25

nECT

Zealand University Hospital

Phase 2 Unknown
40 enrolled
Gastrointestinal

Neoplasms, Neoplastic Processes, Pathologic Processes, Rectal Neoplasms, Colorectal Neoplasms

NCT03225781 2018-12-26

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Universita di Verona

Phase NA Terminated
1 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡